Subtopic Deep Dive

← Medicinal Plants and Bioactive Compounds

Rhodiola Rosea Adaptogenic Activity
Research Guide

What is Rhodiola Rosea Adaptogenic Activity?

Rhodiola rosea adaptogenic activity refers to the plant's ability to enhance nonspecific resistance to stress, reduce fatigue, and improve mental and physical performance through modulation of the HPA axis and neuroendocrine-immune systems.

Rhodiola rosea extracts like SHR-5 demonstrate anti-fatigue effects in double-blind trials on physicians (Darbinyan et al., 2000, 272 citations) and students (Spasov et al., 2000, 231 citations). Key compounds salidroside and rosavin inhibit inflammasomes (Zhu et al., 2017, 820 citations) and protect against stress via SIRT1 pathways (Panossian and Wikman, 2010, 236 citations). Over 10 clinical trials since 2000 validate these effects, with 2000+ total citations across foundational studies.

Curated Papers

Key Challenges

Why It Matters

Rhodiola rosea SHR-5 extract reduced stress-related fatigue in a phase III trial of 60 patients, improving mood and vigor scores by 20-30% (Olsson et al., 2008, 206 citations). Clinical studies show low-dose regimens enhance mental work capacity in physicians during night duty (Darbinyan et al., 2000, 272 citations) and students under exam stress (Spasov et al., 2000, 231 citations). These findings support applications in treating burnout, anxiety, and high-altitude sickness, with Panossian et al. (2009, 183 citations) linking mechanisms to HPA axis regulation for modern stress disorders.

Key Research Challenges

Standardized Extract Variability

Differences in rosavin (3%) and salidroside (1%) content across Rhodiola rosea extracts affect reproducibility, as seen in mouse studies (Perfumi and Mattioli, 2006, 175 citations). Clinical trials use SHR-5 but lack universal standards (Kelly, 2001, 305 citations). This hinders meta-analyses of adaptogenic efficacy.

HPA Axis Mechanism Elucidation

Molecular pathways like SIRT1-NLRP3 inhibition are identified in lung injury models (Zhu et al., 2017, 820 citations), but CNS-specific stress-protective mechanisms remain unclear (Panossian and Wikman, 2010, 236 citations). Animal neuron studies show promise but require human validation. Translation to chronic stress disorders is limited.

Long-Term Clinical Safety

Short-term trials confirm fatigue reduction (Shevtsov et al., 2003, 196 citations), but long-term effects on neuroendocrine systems are untested (Panossian and Wikman, 2009, 183 citations). Dose-response data for repeated low-dose regimens exist but lack multi-year follow-ups. Safety in comorbid populations needs addressing.

Essential Papers

Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome.

Ye Zhu, Yaping Shi, Dan Wu et al. · 2017 · PubMed · 820 citations

Taken together, these findings indicate that SDS may confer protection against ventilation induced lung injury via SIRT1-de-pendent inhibition of NLRP3 inflammasome activation.

Rhodiola rosea: a possible plant adaptogen.

Gregory S. Kelly · 2001 · PubMed · 305 citations

Rhodiola rosea is a popular plant in traditional medical systems in Eastern Europe and Asian with a reputation for stimulating the nervous system, decreasing depression, enhancing work performance,...

Rhodiola rosea in stress induced fatigue — A double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty

V. Darbinyan, A. Kteyan, Alexander Panossian et al. · 2000 · Phytomedicine · 272 citations

Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress—Protective Activity

Alexander Panossian, G. Wikman · 2010 · Pharmaceuticals · 236 citations

Adaptogens were initially defined as substances that enhance the “state of nonspecific resistance” in stress, a physiological condition that is linked with various disorders of the neuroendocrine-i...

Herbal Medicine for Anxiety, Depression and Insomnia

Lei Liu, Changhong Liu, Yicun Wang et al. · 2015 · Current Neuropharmacology · 234 citations

The prevalence and comorbidity of psychiatric disorders such as depression, anxiety and insomnia are very common. These well-known forms of psychiatric disorders have been affecting many people fro...

A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen

А. А. Спасов, G. Wikman, В Б Мандриков et al. · 2000 · Phytomedicine · 231 citations

A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Standardised Extract SHR-5 of the Roots of<i>Rhodiola rosea</i>in the Treatment of Subjects with Stress-Related Fatigue

Erik Olsson, Bo von Schéele, Alexander Panossian · 2008 · Planta Medica · 206 citations

The aim of the study was to assess the efficacy of the standardised extract SHR-5 of roots of Rhodiola Rosea L. in the treatment of individuals suffering from stress-related fatigue. The phase III ...

Reading Guide

Foundational Papers

Start with Kelly (2001, 305 citations) for adaptogen definition and traditional uses; Darbinyan et al. (2000, 272 citations) for first SHR-5 physician trial; Panossian and Wikman (2010, 236 citations) for CNS molecular mechanisms.

Recent Advances

Zhu et al. (2017, 820 citations) for salidroside inflammasome inhibition; Panossian and Wikman (2009, 183 citations) for fatigue evidence synthesis.

Core Methods

Double-blind RCTs with SHR-5 (3% rosavin, 1% salidroside) use low-dose regimens (100-200mg), fatigue inventories (POMS), and biomarkers like cortisol; animal models test acute CNS effects (Perfumi and Mattioli, 2006).

How PapersFlow Helps You Research Rhodiola Rosea Adaptogenic Activity

Discover & Search

PapersFlow's Research Agent uses searchPapers('Rhodiola rosea SHR-5 fatigue trial') to retrieve Darbinyan et al. (2000, 272 citations), then citationGraph to map 10+ interconnected trials by Panossian and Wikman, and findSimilarPapers to uncover Zhu et al. (2017, 820 citations) on salidroside mechanisms.

Analyze & Verify

Analysis Agent applies readPaperContent on Olsson et al. (2008) to extract SHR-5 efficacy stats, verifyResponse with CoVe to cross-check fatigue score improvements against Panossian et al. (2009), and runPythonAnalysis to meta-analyze trial effect sizes using pandas on citation data, with GRADE grading for evidence quality.

Synthesize & Write

Synthesis Agent detects gaps in long-term HPA studies via contradiction flagging across Kelly (2001) and recent works, while Writing Agent uses latexEditText for manuscript sections, latexSyncCitations to integrate 10 Rhodiola papers, and latexCompile for publication-ready reviews with exportMermaid diagrams of adaptogen pathways.

Use Cases

"Run meta-analysis on Rhodiola rosea fatigue trial effect sizes from 2000-2010 papers."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on effect sizes from Darbinyan 2000, Spasov 2000, Olsson 2008) → forest plot output with GRADE scores.

"Draft LaTeX review section on SHR-5 clinical efficacy with citations."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Darbinyan 2000, Panossian 2009) + latexCompile → compiled PDF section with stress-fatigue mechanism figure.

"Find code for analyzing Rhodiola salidroside inflammasome models."

Research Agent → paperExtractUrls (Zhu 2017) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on SIRT1-NLRP3 simulation code → verified model outputs.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ Rhodiola papers: searchPapers → citationGraph → DeepScan 7-step analysis with CoVe checkpoints on Panossian trials → structured report with GRADE tables. Theorizer generates HPA modulation hypotheses from Kelly (2001) and Zhu (2017) mechanisms. DeepScan verifies extract standardization gaps across SHR-5 studies.

Try Doxa for Rhodiola Rosea Adaptogenic Activity Research

Frequently Asked Questions

What defines Rhodiola rosea adaptogenic activity?

Adaptogenic activity enhances nonspecific stress resistance, reduces fatigue, and improves performance via HPA modulation, as defined by Panossian and Wikman (2010) with evidence from SHR-5 trials (Darbinyan et al., 2000).

What are key methods in Rhodiola rosea studies?

Double-blind, placebo-controlled trials with repeated low-dose SHR-5 (200-400mg) assess mental performance in stressed cohorts like physicians (Darbinyan et al., 2000) and students (Spasov et al., 2000), measuring fatigue scales and vigor.

What are the most cited papers?

Zhu et al. (2017, 820 citations) on salidroside-SIRT1; Kelly (2001, 305 citations) review; Darbinyan et al. (2000, 272 citations) physician trial.

What open problems exist?

Long-term safety, standardized dosing beyond SHR-5, and CNS-specific mechanisms lack data (Panossian and Wikman, 2009); human validation of animal SIRT1 pathways needed (Zhu et al., 2017).